|1.||Lerndal, T: 2 articles (03/2000 - 01/2000)|
|2.||Svensson, B: 1 article (03/2000)|
|3.||Masi, A T: 1 article (01/2000)|
|4.||Jónsson, H: 1 article (01/2000)|
|5.||Lien, J: 1 article (01/2000)|
|6.||Hedin, P J: 1 article (01/2000)|
|7.||Carlström, K: 1 article (01/2000)|
|8.||Chatterton, R T: 1 article (01/2000)|
|9.||Jönsson, L: 1 article (01/2000)|
|10.||Weitoft, T: 1 article (01/2000)|
01/01/2000 - "Endocrine effects of the podophyllotoxine derivative drug CPH 82 (Reumacon) in patients with rheumatoid arthritis."
10/01/1989 - "A drug composed of two semisynthetic podophylline derivatives, CPH 82, has recently been launched for the treatment of severe rheumatoid arthritis. "
04/01/1989 - "Podophyllum derivatives (CPH 82) compared with placebo in the treatment of rheumatoid arthritis."
01/01/2000 - "Glucocorticoid-like anti-inflammatory versus immunosuppressive effects of CPH 82 as a single drug therapy of moderately active rheumatoid arthritis patients."
03/01/2000 - "The objectives of this study were to evaluate the therapeutic efficacy of CPH 82 in comparison with methotrexate (MTX) in adult patients with early, active rheumatoid arthritis (RA) and to compare the tolerance and safety profiles of the two drugs. "
01/01/1998 - "As compared with respective baseline values, the CPH-82 group manifested significant improvement in grip strength, Ritchie's articular index (RAI), pain ratings, and HAQ (health assessment questionnaire) scores after 8, 12, 24, and 36 weeks of treatment, with the exception of the 24-week HAQ score. "
01/01/2000 - "CPH 82 (Reumacon) in refractory inflammatory arthritis."
01/01/1993 - "A patient suffering from seronegative polyarthritis was treated with CPH-82 (Reumacon). "
01/01/2000 - "In this retrospective analysis of the DMARD CPH 82 in 44 Icelandic patients with severe refractory arthritis, clinical tolerance was good and serious side effects absent, although the majority were using the drug in combination with other DMARDS. "
|4.||Abdominal Pain (Pain, Abdominal)
|5.||Antirheumatic Agents (DMARD)
|1.||Drug Therapy (Chemotherapy)